US 10093710
Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia
granted A61KA61K38/00A61K38/1793
Quick answer
US patent 10093710 (Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/00, A61K38/1793, A61K38/2086, A61K45/06